Search - tctmd.com

Displaying 201 - 220 of 279

Sort: Relevancy | Date

News Daily News

EVA-3S: La Implantación de Stents Carotídeos y la Endarterectomía arrojan una Eficacia Similar a Largo Plazo

L.A. McKeown

August 07, 2014

News Daily News

EVA-3S: Carotid Stenting, Endarterectomy Show Comparable Long-term Efficacy

L.A. McKeown

August 07, 2014

News Daily News

EVA-3S：颈动脉支架植入术、颈动脉内膜切除术的长期疗效相似

L.A. McKeown

August 07, 2014

News Daily News

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

July 10, 2014

Presentation

Improved Functional Status and QoL in Prohibitive Surgical Risk Patients with Degenerative Mitral Regurgitation After Transcatheter Mitral Valve Repair

Presenter: D.S. Lim

July 07, 2014

Presentation TVT 2014

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Presenter: David J. Cohen

June 07, 2014

News Daily News

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

L.A. McKeown

June 03, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

News Daily News

Octogenarians with AAA Face Higher Mortality, Slower Recovery After Elective EVAR

Caitlin E. Cox

March 27, 2014

News Daily News

研究质疑TAVR改善心理及总体健康状况的能力

L.A. McKeown

March 13, 2014

News Daily News

Study Questions Ability of TAVR to Improve Psychological, General Health

L.A. McKeown

March 13, 2014

News Daily News

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

L.A. McKeown

January 20, 2014

News Daily News

Más Gasto en Pacientes EAP No arroja Beneficio alguno en los Índices de Amputación

December 05, 2013

News Daily News

Higher Spending in PAD Patients Yields No Benefit in Amputation Rates

December 05, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Daily News

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

L.A. McKeown

October 15, 2013

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

News Daily News

COURAGE: 医药治疗‘跨越’是因出现更多症状而非更多硬事件

July 19, 2013

News Daily News

COURAGE: Medical Therapy ‘Crossovers’ Have More Symptoms, not More Hard Events

July 19, 2013

Advertisement

EVA-3S: La Implantación de Stents Carotídeos y la Endarterectomía arrojan una Eficacia Similar a Largo Plazo

EVA-3S: Carotid Stenting, Endarterectomy Show Comparable Long-term Efficacy

EVA-3S：颈动脉支架植入术、颈动脉内膜切除术的长期疗效相似

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

Improved Functional Status and QoL in Prohibitive Surgical Risk Patients with Degenerative Mitral Regurgitation After Transcatheter Mitral Valve Repair

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

Octogenarians with AAA Face Higher Mortality, Slower Recovery After Elective EVAR

研究质疑TAVR改善心理及总体健康状况的能力

Study Questions Ability of TAVR to Improve Psychological, General Health

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

Más Gasto en Pacientes EAP No arroja Beneficio alguno en los Índices de Amputación

Higher Spending in PAD Patients Yields No Benefit in Amputation Rates

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

COURAGE: 医药治疗‘跨越’是因出现更多症状而非更多硬事件

COURAGE: Medical Therapy ‘Crossovers’ Have More Symptoms, not More Hard Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content